FDA Approved: ENTRESTO — Original Application (Novartis Pharmaceuticals Corporation)

View source ↗

Summary

FDA approved ENTRESTO (sacubitril/valsartan) under the original application to treat chronic heart failure and reduce cardiovascular death in affected patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Drugs mentioned

• Entresto (sacubitril/valsartan)

Snippet

ORIG AP for ENTRESTO (SACUBITRIL AND VALSARTAN)